AI for Pharmaceutical Development: Using Artificial Intelligence in Formulation, Manufacturing, Quality, Clinical Development, and Regulatory Science

Información para AI Search

AI for Pharmaceutical Development: Using Artificial Intelligence in Formulation, Manufacturing, Quality, Clinical Development, and Regulatory Science

Author: Mason Clark

Description: Artificial intelligence promises to transform pharmaceutical development, yet the gap between hype and compliant deployment remains wide. How do you use AI to accelerate formulation, optimize manufacturing, or streamline regulatory submissions without compromising data integrity or regulatory responsibility? AI for Pharmaceutical Development bridges that gap. This practical, vendor-neutral guide maps AI capabilities to the post-discovery lifecycle, from formulation and quality by design through clinical development, regulatory science, and pharmacovigilance. It offers step-by-step workflows, decision matrices, and compliance checkpoints that pharmaceutical professionals can apply immediately. The book is built on a core premise: AI is a powerful decision-support tool, not a replacement for scientific judgment or GMP compliance. Every chapter enforces this boundary with explicit validation requirements, human oversight protocols, and risk-based use case distinctions. • Maps six stages of pharmaceutical development and shows exactly where AI can add value. • Establishes data readiness, integrity, confidentiality, and organizational governance before domain applications. • Demonstrates AI-assisted workflows for formulation strategy, excipient selection, QbD/DoE, stability, PAT, deviation investigation, clinical trial monitoring, regulatory writing, and pharmacovigilance. This book was written for practicing scientists and engineers in regulated environments. Formulation scientists, manufacturing engineers, QA/QC specialists, clinical development professionals, regulatory affairs officers, and pharmacovigilance experts will find actionable guidance grounded in real-world tasks and regulatory expectations. If your organization is exploring AI in pharmaceutical development, this is the resource to ensure you move forward with clarity, confidence, and full compliance.

AI summary: AI for Pharmaceutical Development is a practical guide for pharmaceutical professionals on using AI across the drug development lifecycle after discovery. Covering formulation, manufacturing, quality, clinical development, regulatory science, and pharmacovigilance, it emphasizes responsible AI use with human oversight and compliance. The book provides step-by-step workflows, decision matrices, and validation requirements tailored to regulated environments.

Ideal para

Pharmaceutical development professionals including formulation scientists, manufacturing engineers, QA/QC specialists, clinical development scientists, regulatory affairs professionals, and pharmacovigilance experts.

Perfil del lector

A pharmaceutical scientist or engineer seeking practical, compliant AI integration into daily workflows without compromising data integrity or regulatory responsibility.

Intención de búsqueda

Pharmaceutical professionals looking for practical guidance on applying AI to drug development tasks while maintaining GMP compliance and scientific rigor.

Enfoque único

Unlike generic AI books, this guide is built around real pharmaceutical development tasks and enforces compliance boundaries at every step, making it actionable for regulated environments.

Tipo de contenido

practical guide

Resumen rápido

• This book maps AI capabilities to six stages of pharmaceutical development: formulation, manufacturing, quality, clinical, regulatory, and pharmacovigilance.
• It teaches how to use AI for excipient selection, design of experiments, stability analysis, deviation investigation, protocol review, and safety signal detection.
• Every workflow includes validation requirements, human oversight protocols, and risk-based distinctions between exploratory and regulated AI use.
• The book is vendor-neutral and focuses on practical tasks, not AI theory or software promotions.

Key topics: Formulation development, Quality by Design, Design of Experiments, Excipient selection, Stability studies, Process Analytical Technology, Manufacturing optimization, Deviation investigation, Clinical trial monitoring, Regulatory intelligence, Pharmacovigilance, Responsible AI

Entities: AI, pharmaceutical development, formulation science, manufacturing, quality control, clinical trials, regulatory affairs, pharmacovigilance, GMP, data integrity, decision support, human oversight

Necesidades cubiertas

• How to integrate AI into formulation and manufacturing without compromising compliance
• How to use AI for regulatory writing and pharmacovigilance safely
• How to distinguish exploratory AI use from validated workflows
• How to build organizational AI governance in pharma

Léelo si

• Formulation scientists
• Manufacturing engineers
• QA/QC specialists
• Clinical development scientists
• Regulatory affairs professionals
• Pharmacovigilance experts

Puede no encajar si

• Readers seeking deep machine learning theory or programming tutorials
• Those looking for a vendor-specific software manual
• General audience without pharmaceutical background

Índice

1. Introduction (introduction)
2. Foundations of AI-Assisted Pharmaceutical Development (part)
3. AI Across the Pharmaceutical Development Lifecycle (chapter)
4. From Discovery to Development (section)
5. Where AI Supports Pharmaceutical Development (section)
6. Exploratory AI vs Regulated AI Use (section)
7. The Development Workflow of This Book (section)
8. Data, Documentation, and AI Readiness (chapter)
9. Types of Data in Pharmaceutical Development (section)
10. Data Quality and Data Integrity (section)
11. Preparing Data for AI-Assisted Analysis (section)
12. Confidentiality and Access Control (section)
13. Responsible AI in Regulated Pharmaceutical Environments (chapter)
14. AI as Decision Support, Not Decision Authority (section)
15. Risk-Based AI Use (section)
16. Validation, Documentation, and Auditability (section)
17. Organizational AI Governance (section)
18. AI for Formulation and Product Development (part)
19. AI-Assisted Formulation Strategy (chapter)
20. Understanding the Formulation Challenge (section)
21. Comparing Formulation Approaches (section)
22. Literature-Guided Formulation Planning (section)
23. Avoiding Overgeneralized Formulation Suggestions (section)
24. AI for Excipient Selection and Compatibility (chapter)
25. The Role of Excipients in Development (section)
26. AI-Assisted Excipient Comparison (section)
27. Compatibility and Risk Assessment (section)
28. Building an Excipient Decision Matrix (section)
29. Quality by Design and Design of Experiments (chapter)
30. Introduction to Quality by Design (section)
31. AI Support for Risk Assessment (section)
32. Design of Experiments Planning (section)
33. Interpreting DoE Outputs Carefully (section)
34. Stability Study Planning and Interpretation (chapter)
35. The Role of Stability in Product Development (section)
36. AI-Assisted Stability Study Planning (section)
37. Interpreting Stability Trends (section)
38. Limitations of AI in Stability Prediction (section)
39. AI for Pharmaceutical Analysis Support (chapter)
40. Analytical Method Development Context (section)
41. AI-Assisted Method Comparison (section)
42. Data Review and Trend Interpretation (section)
43. Validation Boundaries (section)
44. AI for Manufacturing, Quality, and Process Optimization (part)
45. AI in Pharmaceutical Manufacturing (chapter)
46. Manufacturing as a Data-Rich Environment (section)
47. AI for Process Understanding (section)
48. AI-Assisted Process Optimization (section)
49. Human and GMP Oversight (section)
50. Process Analytical Technology and Real-Time Monitoring (chapter)
51. What PAT Tries to Achieve (section)
52. AI and Multivariate Process Data (section)
53. Detecting Process Drift (section)
54. PAT Limitations and Validation Needs (section)
55. Digital Twins and Continuous Manufacturing (chapter)
56. Digital Twins in Pharmaceutical Development (section)
57. AI-Assisted Simulation and Prediction (section)
58. Continuous Manufacturing Workflows (section)
59. Risks of Overreliance on Simulated Systems (section)
60. AI for Quality Control and Deviation Investigation (chapter)
61. Quality Data and Batch Review (section)
62. AI-Assisted Deviation Analysis (section)
63. Root Cause Analysis Support (section)
64. Documentation and Human Approval (section)
65. Predictive Maintenance and Supply Chain Intelligence (chapter)
66. Equipment and Maintenance Data (section)
67. AI for Predictive Maintenance (section)
68. Supply Chain and Inventory Forecasting (section)
69. Risk Management in Operations (section)
70. AI for Clinical Development (part)
71. AI-Assisted Clinical Development Planning (chapter)
72. From Preclinical Evidence to Clinical Strategy (section)
73. AI Support for Protocol Analysis (section)
74. Patient Population and Recruitment Feasibility (section)
75. Limits of AI in Clinical Development (section)
76. Biomarkers, Subgroups, and Evidence Interpretation (chapter)
77. Biomarkers in Drug Development (section)
78. AI for Biomarker Discovery Support (section)
79. Subgroup and Stratification Analysis (section)
80. Evidence Interpretation and Validation (section)

Preguntas frecuentes